Update on Prenatal Detection Rate of Critical Congenital Heart Disease Before and During the COVID-19 Pandemic.

Access to health care COVID-19 Congenital heart defects Echocardiography

Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
03 Apr 2024
Historique:
received: 04 01 2024
accepted: 25 03 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 2 4 2024
Statut: aheadofprint

Résumé

Prenatal diagnosis of critical congenital heart disease (CCHD) has improved over time, and previous studies have identified CCHD subtype and socioeconomic status as factors influencing rates of prenatal diagnosis. Our objective of this single-center study was to compare prenatal diagnosis rates of newborns with CCHD admitted for cardiac intervention from the COVID-19 pandemic period (March 2020 to March 2021) to the pre-pandemic period and identify factors associated with the lack of CCHD prenatal diagnosis. The overall rate of CCHD and rates of the various CCHD diagnoses were calculated and compared with historical data collection periods (2009-2012 and 2013-2016). Compared with the 2009-2012 pre-pandemic period, patients had 2.17 times higher odds of having a prenatal diagnosis of CCHD during the pandemic period controlling for lesion type (aOR = 2.17, 95% CI 1.36-3.48, p = 0.001). Single ventricle lesions (aOR 6.74 [4.64-9.80], p < 0.001) and outflow tract anomalies (aOR 2.20 [1.56-3.12], p < 0.001) had the highest odds of prenatal diagnosis compared with the remaining lesions. Patients with outflow tract anomalies had higher odds for prenatal detection in the pandemic period compared with during the 2009-2012 pre-pandemic period (aOR 2.01 [1.06-3.78], p = 0.031). In conclusion, prenatal detection of CCHD among newborns presenting for cardiac intervention appeared to have improved during the pandemic period.

Identifiants

pubmed: 38565667
doi: 10.1007/s00246-024-03487-9
pii: 10.1007/s00246-024-03487-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Tsao CW, Aday AW, Almarzooq ZI et al (2022) Heart Disease and Stroke Statistics-2022 update: a Report from the American Heart Association. Circulation 145(8):e153–e639. https://doi.org/10.1161/CIR.0000000000001052
doi: 10.1161/CIR.0000000000001052 pubmed: 35078371
Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900. https://doi.org/10.1016/s0735-1097(02)01886-7
doi: 10.1016/s0735-1097(02)01886-7 pubmed: 12084585
van der Linde D, Konings EE, Slager MA et al (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241–2247. https://doi.org/10.1016/j.jacc.2011.08.025
doi: 10.1016/j.jacc.2011.08.025 pubmed: 22078432
GBD 2017 Congenital Heart Disease Collaborators (2020) Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet Child Adolesc Health 4(3):185–200. https://doi.org/10.1016/S2352-4642(19)30402-X
doi: 10.1016/S2352-4642(19)30402-X
Schultz AH, Localio AR, Clark BJ et al (2008) Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics 121(4):751–757. https://doi.org/10.1542/peds.2007-0421
doi: 10.1542/peds.2007-0421 pubmed: 18381540
Cloete E, Bloomfield FH, Sadler L et al (2019) Antenatal detection of treatable critical congenital heart disease is associated with lower morbidity and mortality. J Pediatr 204:66–70. https://doi.org/10.1016/j.jpeds.2018.08.056
doi: 10.1016/j.jpeds.2018.08.056 pubmed: 30292491
Quartermain MD, Pasquali SK, Hill KD et al (2015) Variation in prenatal diagnosis of congenital heart disease in infants. Pediatrics 136(2):e378–e385. https://doi.org/10.1542/peds.2014-3783
doi: 10.1542/peds.2014-3783 pubmed: 26216324
Campbell MJ, Lorch S, Rychik J et al (2021) Socioeconomic barriers to prenatal diagnosis of critical congenital heart disease. Prenat Diagn 41(3):341–346. https://doi.org/10.1002/pd.5864
doi: 10.1002/pd.5864 pubmed: 33169368
Peiris V, Singh TP, Tworetzky W et al (2009) Association of socioeconomic position and medical insurance with fetal diagnosis of critical congenital heart disease. Circ Cardiovasc Qual Outcomes 2(4):354–360. https://doi.org/10.1161/CIRCOUTCOMES.108.802868
doi: 10.1161/CIRCOUTCOMES.108.802868 pubmed: 20031861
Hill GD, Block JR, Tanem JB, Frommelt MA (2015) Disparities in the prenatal detection of critical congenital heart disease. Prenat Diagn 35(9):859–863. https://doi.org/10.1002/pd.4622
doi: 10.1002/pd.4622 pubmed: 25989740 pmcid: 4558244
Kim Y, Gordon A, Rowerdink K et al (2022) The impact of the COVID-19 pandemic on health care utilization among insured individuals with common chronic conditions. Med Care 60(9):673–679. https://doi.org/10.1097/MLR.0000000000001747
doi: 10.1097/MLR.0000000000001747 pubmed: 35866561 pmcid: 9365072
Xu S, Glenn S, Sy L et al (2021) Impact of the COVID-19 pandemic on health care utilization in a large integrated health care system: retrospective cohort study. J Med Internet Res 23(4):e26558. https://doi.org/10.2196/26558
doi: 10.2196/26558 pubmed: 33882020 pmcid: 8086778
Abu-Rustum RS, Akolekar R, Sotiriadis A et al (2020) ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID-19. Ultrasound Obstet Gyencol 55(6):863–870. https://doi.org/10.1002/uog.22029
doi: 10.1002/uog.22029
The Society for Maternal-Fetal Medicine (2020) COVID-19 Ultrasound Clinical Practice Suggestions https://s3.amazonaws.com/cdn.smfm.org/media/2550/Ultrasound_Covid19_Suggestions_10-20-20_(final).pdf
Boelig RC, Saccone G, Bellussi F, Berghella V (2020) MFM guidance for COVID-19. Am J Obstet Gynecol MFM 2(2):100106. https://doi.org/10.1016/j.ajogmf.2020.100106
doi: 10.1016/j.ajogmf.2020.100106 pubmed: 32363335 pmcid: 7195418
Kirkpatrick JN, Mitchell C, Taub C et al (2020) ASE Statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: endorsed by the American College of Cardiology. J Am Coll Cardiol 75(24):3078–3084. https://doi.org/10.1016/j.jacc.2020.04.002
doi: 10.1016/j.jacc.2020.04.002 pubmed: 32272153 pmcid: 7194625
Barker PCA, Lewin MB, Donofrio MT et al (2020) Specific considerations for pediatric, fetal, and congenital heart disease patients and echocardiography service providers during the 2019 novel coronavirus outbreak: Council on Pediatric and congenital heart Disease supplement to the Statement of the American Society of Echocardiography: endorsed by the Society of Pediatric Echocardiography and the fetal Heart Society. J Am Soc Echocardiogr 33(6):658–665. https://doi.org/10.1016/j.echo.2020.04.005
doi: 10.1016/j.echo.2020.04.005 pubmed: 32503702 pmcid: 7144602
Boguslawski SM, Joseph NT, Stanhope KK et al (2022) Impact of the COVID-19 pandemic on prenatal care utilization at a public hospital. Am J Perinatol. https://doi.org/10.1055/a-1877-7951
doi: 10.1055/a-1877-7951 pubmed: 35709724
Kern-Goldberger AR, Sheils NE, Ventura MEM et al (2023) Patterns of prenatal care delivery and obstetric outcomes before and during the COVID-19 pandemic. Am J Perinatol 40(6):582–588. https://doi.org/10.1055/a-1960-2682
doi: 10.1055/a-1960-2682 pubmed: 36228651
Ronai C, Canty E, Kim A et al (2021) Abstract 11221: counseling in the time of COVID – prenatal diagnosis of congenital heart disease during a pandemic. Circulation 144:A11211. https://doi.org/10.1161/circ.144.suppl_1.11221
doi: 10.1161/circ.144.suppl_1.11221
Pinto NM, Keenan HT, Minich LL et al (2012) Barriers to prenatal detection of congenital heart disease: a population-based study. Ultrasound Obstet Gynecol 40(4):418–425. https://doi.org/10.1002/uog.10116
doi: 10.1002/uog.10116 pubmed: 21998002
American Institute of Ultrasound in Medicine (2013) AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 32(6):1083–1101. https://doi.org/10.7863/ultra.32.6.1083
doi: 10.7863/ultra.32.6.1083
AIUM-ACR-ACOG-SMFM-SRU (2018) Practice parameter for the performance of Standard Diagnostic Obstetric Ultrasound examinations. J Ultrasound Med 37(11):E13–E24. https://doi.org/10.1002/jum.14831
doi: 10.1002/jum.14831
AIUM Practice Parameter for the Performance of Fetal Echocardiography (2020) J Ultrasound Med 39(1):E5–E16. https://doi.org/10.1002/jum.15188
doi: 10.1002/jum.15188
Ailes EC, Gilboa SM, Riehle-Colarusso T, National Birth Defects Prevention Study et al (2014) Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn 34(3):214–222. https://doi.org/10.1002/pd.4282
doi: 10.1002/pd.4282 pubmed: 24222433

Auteurs

Deepak Gupta (D)

Children's Hospital Los Angeles, Department of Pediatrics, Los Angeles, California, USA.

Tiffany Vuong (T)

Keck School of Medicine of USC, Los Angeles, California, USA.

Shuo Wang (S)

Children's Hospital Los Angeles, Division of Cardiology, Keck School of Medicine of USC, Los Angeles, California, USA.

Lisa M Korst (LM)

Childbirth Research Associates, LLC, North Hollywood, Los Angeles, California, USA.

Jay D Pruetz (JD)

Children's Hospital Los Angeles, Division of Cardiology, Fetal Cardiology Program, Keck School of Medicine of USC, 4650 Sunset Blvd, Los Angeles, California, 90027, USA. jpruetz@chla.usc.edu.

Classifications MeSH